Brolucizumab: Solution for intravitreal injection 19.8 mg in 0.165 mL pre-filled syringe; Beovu® Page last updated: 2 July 2021 Public Summary Document (PSD) March 2021 PBAC Meeting - (PDF 1144KB) Public Summary Document (PSD) March 2021 PBAC Meeting - (Word 110KB)